Published in J Virol on May 01, 2000
Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol (2001) 2.08
The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J Virol (2003) 1.84
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J Virol (2002) 1.77
The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J Virol (2002) 1.52
Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J Virol (2003) 1.43
Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of infection. J Virol (2002) 1.42
VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J Virol (2006) 1.41
Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J Virol (2003) 1.36
Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment. J Virol (2002) 1.35
Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J Virol (2003) 1.31
Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther (2005) 1.30
Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. J Virol (2003) 1.24
Intracellular transport of hepatitis B virus. World J Gastroenterol (2007) 1.14
Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus. J Virol (2002) 1.14
Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction. J Virol (2002) 1.13
Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J Virol (2010) 1.04
Virus strategies for passing the nuclear envelope barrier. Nucleus (2012) 0.98
Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus. J Virol (2009) 0.97
Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. J Virol (2004) 0.96
Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3'-to-5' genome uncoating and critically impair entry functions. J Virol (2011) 0.95
Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis. PLoS Pathog (2013) 0.90
Pathways of cell infection by parvoviruses and adeno-associated viruses. J Virol (2004) 0.89
Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction. Virology (2007) 0.84
Characterization of the early steps of human parvovirus B19 infection. J Virol (2012) 0.81
Parvovirus particles and movement in the cellular cytoplasm and effects of the cytoskeleton. Virology (2014) 0.76
Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking. Viruses (2014) 0.76
The potential role of microfilaments in host cells for infection with infectious spleen and kidney necrosis virus infection. Virol J (2013) 0.75
Parvovirus capsid structures required for infection: mutations controlling receptor recognition and protease cleavages. J Virol (2016) 0.75
Nucleocytoplasmic transport. Science (1996) 8.76
Virus entry into animal cells. Adv Virus Res (1989) 7.78
Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 6.34
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol (1996) 6.22
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol (1996) 5.94
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol (1997) 5.66
Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus. J Cell Biol (1999) 4.00
Unpacking the incoming influenza virus. Cell (1992) 3.24
Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell (1996) 3.23
Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol (1989) 3.06
Transport of incoming influenza virus nucleocapsids into the nucleus. J Virol (1991) 2.92
The effects of variations in the number and sequence of targeting signals on nuclear uptake. J Cell Biol (1988) 2.89
The entry of enveloped viruses into cells by endocytosis. Biochem J (1984) 2.83
Physical properties of cytoplasm. Curr Opin Cell Biol (1994) 2.81
Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J Virol (1988) 2.72
The role of the nuclear pore complex in adenovirus DNA entry. EMBO J (1997) 2.37
Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology (1991) 2.20
Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J Virol (1992) 2.15
Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol (1996) 2.08
Infectious entry pathway of adenovirus type 2. J Virol (1991) 2.06
Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther (1998) 2.06
Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J Virol (1997) 2.00
Structure determination of feline panleukopenia virus empty particles. Proteins (1993) 1.99
Dynamin is required for recombinant adeno-associated virus type 2 infection. J Virol (1999) 1.99
Uncoating of human rhinovirus serotype 2 from late endosomes. J Virol (1994) 1.96
Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J Cell Biol (1999) 1.92
Nuclear import and export of viruses and virus genomes. Virology (1998) 1.91
Mechanism of entry of human rhinovirus 2 into HeLa cells. Virology (1987) 1.77
Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J Virol (2000) 1.61
Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology (1999) 1.60
Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol (1999) 1.59
Extracellular simian virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp Cell Res (1999) 1.59
How do animal DNA viruses get to the nucleus? Annu Rev Microbiol (1998) 1.59
Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2. J Cell Biol (1995) 1.55
Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA. Proc Natl Acad Sci U S A (1996) 1.53
Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J Virol (1992) 1.51
Import of simian virus 40 virions through nuclear pore complexes. Proc Natl Acad Sci U S A (1991) 1.47
Mechanisms of virus uncoating. Trends Microbiol (1994) 1.32
Role of nuclear pore complex in simian virus 40 nuclear targeting. J Virol (1993) 1.29
The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol (1996) 1.24
Mapping of determinants of the host range for canine cells in the genome of canine parvovirus using canine parvovirus/mink enteritis virus chimeric viruses. J Gen Virol (1994) 1.23
Monoclonal antibodies to the major nonstructural nuclear protein of minute virus of mice. Virology (1991) 1.20
Infectious entry pathway for canine parvovirus. Virology (1992) 1.19
Early events in polyomavirus infection: fusion of monopinocytotic vesicles containing virions with mouse kidney cell nuclei. Virus Res (1988) 1.19
Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur J Biochem (1997) 1.14
Effects of inhibitors of the cytoplasmic structures and functions on the early phase of infection of cultured cells with simian virus 40. Virology (1987) 1.09
Assaying for structural variation in the parvovirus capsid and its role in infection. Virology (1998) 1.08
Intracellular route of canine parvovirus entry. J Virol (1998) 1.05
Cellular uptake and nuclear delivery of recombinant adenovirus penton base. Virology (1999) 1.01
Fluorescent viral vectors: a new technique for the pharmacological analysis of gene therapy. Nat Med (1998) 0.97
Ultrastructural studies of H-1 parvovirus replication. III. Intracellular localization of viral antigens with immunocytochrome c. Exp Cell Res (1976) 0.96
Entry and uncoating of enveloped viruses. Biochem J (1994) 0.95
Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Virology (2000) 0.93
Replication of minute virus of mice DNA in adenovirus-infected or adenovirus-transformed cells. Virology (1990) 0.86
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res (2001) 5.08
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol (1996) 4.86
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol (1995) 4.15
Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res (1999) 3.35
Conversion of diploidy to haploidy. Nature (2000) 3.28
Interfacial catalysis: the mechanism of phospholipase A2. Science (1990) 2.84
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology (2000) 2.64
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell (1999) 2.35
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol (1999) 2.20
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release (2001) 2.15
Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J Virol (1992) 2.15
Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J Virol (2001) 2.08
Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J Virol (1997) 2.00
Structure determination of feline panleukopenia virus empty particles. Proteins (1993) 1.99
Natural variation of canine parvovirus. Science (1985) 1.89
Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod (2009) 1.87
Evolution of the feline-subgroup parvoviruses and the control of canine host range in vivo. J Virol (1995) 1.74
Evolution of canine parvovirus involved loss and gain of feline host range. Virology (1996) 1.73
Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology (1994) 1.67
1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int (2007) 1.64
Shanghai premarital adolescent use of contraceptive methods and analysis of influencing factors. Chin J Popul Sci (1997) 1.64
Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J Virol (1992) 1.61
Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J Virol (2000) 1.61
Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev (2008) 1.60
Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob Agents Chemother (1997) 1.59
Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology (1994) 1.58
Characterization and recombination mapping of an antigenic and host range mutation of canine parvovirus. Virology (1986) 1.56
Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem (2000) 1.55
Ca(2+) influx through Ca(2+) channels in rabbit ventricular myocytes during action potential clamp: influence of temperature. Circ Res (1999) 1.52
Antigenic structure and variation of canine parvovirus type-2, feline panleukopenia virus, and mink enteritis virus. Virology (1983) 1.51
Type I error in sample size re-estimations based on observed treatment difference. Stat Med (2001) 1.50
Os odontoideum: etiology, diagnosis, and management. Surg Neurol (2000) 1.48
Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch Virol (1982) 1.38
Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid. Virology (1995) 1.37
Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J Cell Physiol (2000) 1.36
Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol (1992) 1.34
Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding. Virology (1992) 1.33
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology (2007) 1.33
Structural analysis of a mutation in canine parvovirus which controls antigenicity and host range. Virology (1996) 1.33
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
The structure of a neutralized virus: canine parvovirus complexed with neutralizing antibody fragment. Structure (1994) 1.30
Host range and variability of calcium binding by surface loops in the capsids of canine and feline parvoviruses. J Mol Biol (2000) 1.26
Characterization of the feline host range and a specific epitope of feline panleukopenia virus. Virology (1994) 1.25
A novel variant of avian infectious bronchitis virus resulting from recombination among three different strains. Arch Virol (1995) 1.22
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther (1999) 1.22
Mechanistic studies on class I polyhydroxybutyrate (PHB) synthase from Ralstonia eutropha: class I and III synthases share a similar catalytic mechanism. Biochemistry (2001) 1.21
Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene (2000) 1.19
Semi-automated color segmentation of anatomical tissue. Comput Med Imaging Graph (2000) 1.18
Three closely related herpesviruses are associated with fibropapillomatosis in marine turtles. Virology (1998) 1.18
PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Biochem Biophys Res Commun (2010) 1.17
Parvovirus infections in wild carnivores. J Wildl Dis (2001) 1.17
Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem (1999) 1.14
Nonstructural protein-2 and the replication of canine parvovirus. Virology (1998) 1.13
The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis. Mol Cell Biol (2000) 1.12
Detection by PCR of wild-type canine parvovirus which contaminates dog vaccines. J Clin Microbiol (1995) 1.12
Identification of distinct subpopulations of intercalated cells in the mouse collecting duct. J Am Soc Nephrol (1996) 1.11
Detection of a novel bovine lymphotropic herpesvirus. J Virol (1998) 1.10
Assaying for structural variation in the parvovirus capsid and its role in infection. Virology (1998) 1.08
Cryphonectria hypovirus 3, a virus species in the family hypoviridae with a single open reading frame. Virology (1999) 1.04
Radiculopathy after laminectomy for cervical compression myelopathy. J Bone Joint Surg Br (1998) 1.04
Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin. Virology (2000) 1.02
Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors. Leukemia (2007) 1.01
Cardiac myocyte volume, Ca2+ fluxes, and sarcoplasmic reticulum loading in pressure-overload hypertrophy. Am J Physiol (1997) 1.00
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone (1996) 1.00
Characterization of antigenic variation among mink enteritis virus isolates. Am J Vet Res (1984) 0.99
Direct repair of defect in lumbar spondylolysis and mild isthmic spondylolisthesis by bone grafting, with or without facet joint fusion. Eur Spine J (2001) 0.97
The use of a zero-profile device compared with an anterior plate and cage in the treatment of patients with symptomatic cervical spondylosis: A preliminary clinical investigation. Bone Joint J (2013) 0.97
Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett (1994) 0.97
Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology (2001) 0.96
Competitive inhibition of phospholipase A2 in vesicles. Biochemistry (1989) 0.96
Analysis of surface deposits on intrauterine contraceptive devices. Adv Contracept (1986) 0.95
Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Virology (2000) 0.93
Marked transaminase elevation in anorexia nervosa. Dig Dis Sci (2000) 0.93
Surgical treatment of nonunited fractures of the odontoid process, with special reference to occipitocervical fusion for unreducible atlantoaxial subluxation or instability. Eur Spine J (2000) 0.93
Antigenic type distribution among canine parvoviruses in dogs and cats in Germany. Vet Rec (1996) 0.92
Restimulated memory Tc cells have a higher apparent avidity of interaction with targets than primary virus-immune Tc cells as indicated by anti-CD8 blocking. Immunol Cell Biol (1992) 0.92
Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial. Clin Ther (1999) 0.92
Antigenic and genetic analysis of canine parvoviruses in southern Africa. Onderstepoort J Vet Res (1998) 0.92
Characterization of minute virus of canines (MVC) and its pathogenicity for pups. Cornell Vet (1988) 0.92
DTI values in key white matter tracts from infancy through adolescence. AJNR Am J Neuroradiol (2013) 0.91
Real-time protein biosensor arrays based on surface plasmon resonance differential phase imaging. Biosens Bioelectron (2008) 0.91
Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions. Peptides (2000) 0.90
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design. J Med Chem (1998) 0.89
Feline calicivirus capsid protein expression and capsid assembly in cultured feline cells. J Virol (1999) 0.88
Determination of the detection limit of the polymerase chain reaction for chicken infectious anemia virus. Avian Dis (1993) 0.88
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activation. J Thromb Haemost (2009) 0.88
Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int (1998) 0.88
Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes. J Pharmacol Exp Ther (1995) 0.87
Evidence for separate control of slow version and vergence eye movements: support for Hering's Law. Vision Res (1998) 0.87
Satellite and defective RNAs of Cryphonectria hypovirus 3-grand haven 2, a virus species in the family Hypoviridae with a single open reading frame. Virology (2000) 0.87
Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression. J Virol (1992) 0.87
Assessment of equivalence on multiple endpoints. Stat Med (2001) 0.87
White matter microstructural abnormality in children with hydrocephalus detected by probabilistic diffusion tractography. AJNR Am J Neuroradiol (2013) 0.85
Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA. Chem Res Toxicol (1994) 0.85